- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.01. | Sanofi's RSV antibody Beyfortus, after smashing blockbuster sales threshold, still has room to grow in US: execs | ||
| 30.01. | Vabysmo crosses $4B mark, Polivy joins blockbuster club as Roche preps for key readouts | ||
| 30.01. | Upperton expands footprint with addition of UK sterile production plant | ||
| 30.01. | CDMO Rentschler winds down operations at UK cell and gene therapy plant in strategic shift toward biologics | ||
| 30.01. | Takeda taps Julie Kim to take over for retiring CEO Christophe Weber | ||
| 30.01. | While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year | ||
| 29.01. | Teva, despite delivering in 2024, startles investors with subdued 2025 guidance | ||
| 29.01. | As RFK Jr. faces Senate, survey shows widespread support for access to vaccines | ||
| 29.01. | Senators re-up call to include prices in DTC drug ads | ||
| 29.01. | US government agencies file objection to J&J's $9B talc bankruptcy settlement | ||
| 29.01. | CMI survey suggests obesity patients' love of streaming TV comedies, dramas paves a path for pharma advertisers | ||
| 28.01. | Novo Nordisk expands Ozempic's turf with new FDA nod to curb kidney disease risks | ||
| 28.01. | Roche's breast cancer entrant Itovebi bolsters clinical profile with overall survival win | ||
| 28.01. | Trump's foreign aid freeze threatens global HIV, malaria drug supply from USAID: reports | ||
| 28.01. | Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June | ||
| 28.01. | AstraZeneca, Daiichi's Enhertu nabs 7th FDA nod, including in 'HER2-ultralow' use, in breast cancer first | ||
| 28.01. | Lantheus lays out $250M+ to get its hands on radiopharma developer and CDMO Evergreen | ||
| 27.01. | No deal: Sage rejects Biogen's buyout offer, scouts for strategic alternatives | ||
| 27.01. | Pfizer's board untouched before annual meeting as proxy fight with Starboard rolls on: Bloomberg | ||
| 27.01. | Moderna, Novo Nordisk slammed for breaching UK drug marketing code yet again | ||
| 27.01. | Gearing up to challenge Lilly in obesity, Kailera picks Zepbound brand leader as new commercial chief | ||
| 27.01. | Pfizer shells out nearly $60M to resolve Nurtec kickback claims inherited in Biohaven buyout | ||
| 27.01. | Havas Life London rises from rebrand with eye on global health and rare disease communication | ||
| 24.01. | Takeda bids adieu to Uloric after gout med's gradual fade from glory | ||
| 24.01. | Fujifilm Diosynth CEO heralds 2025 as 'biggest year' yet for CDMO's $8B+ expansion drive |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
